PedAM

Pediatric Disease Annotations & Medicines

Disease	eye disease
Phenotype	C0011884\|diabetic retinopathy
Sentences	4
PubMedID- 23663422	With type 2 diabetes mellitus, pandemic and its severe secondary complication such as stroke, 50% of people after 85 years of age affected by alzheimer's disease (also diagnosed as type 3 diabetes) and neurodegenerative eye diseases with leading causes of blindness, diabetic retinopathy and estimated 70 million glaucoma patients worldwide, millions of patients with parkinson’s disease, multiple sclerosis, epilepsy and dementia in the elderly—altogether dramatically affect life quality and social and economic indexes of populations around the globe.
PubMedID- 23199059	Current figures: about 300 million diabetics frequently affected by poly-neuropathy as secondary complication, 18 million patients with alzheimer’s disease also diagnosed as diabetes type 3, neurodegenerative eye diseases with leading causes of blindness—diabetic retinopathy and estimated 67 million glaucoma patients worldwide, millions of patients with parkinson’s disease, multiple sclerosis, epilepsy, cerebral palsy and dementia in the elderly—altogether dramatically affect life quality, social and economical indexes of populations around the globe.
PubMedID- 24708704	Over 300 million diabetics frequently affected by poly-neuropathy as secondary complication, 18 million patients with alzheimer's disease (also diagnosed as diabetes type 3), neurodegenerative eye diseases with leading causes of blindness—diabetic retinopathy and estimated 70 million glaucoma patients worldwide, millions of patients with parkinson's disease, multiple sclerosis, epilepsy, cerebral palsy and dementia in the elderly—these are all the patient cohorts with severe neurological disorders, who demonstrate dramatically decreased life quality.
PubMedID- 23920536	Introduction: screening guidelines for diabetic patients recommend yearly eye examinations to detect diabetic retinopathy and other forms of diabetic eye disease.

Page: 1